Macquarie Group’s GoodRx Holdings GDRX Stock Holding History

Macquarie Group’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,776	Closed	-$91K	–	2629
2021 Q4	$91K	Sell	2,776 -710	-20%	-$28.6K	﹤0.01%	1968
2021 Q3	$143K	Sell	3,486 -223	-6%	-$8.09K	﹤0.01%	1868
2021 Q2	$134K	Sell	3,709 -471	-11%	-$17.4K	﹤0.01%	1886
2021 Q1	$163K	Buy	+4,180	New	+$188K	﹤0.01%	1766
2020 Q4	–	Sell	-10,440	Closed	-$580K	–	2363
2020 Q3	$580K	Buy	+10,440	New	+$553K	﹤0.01%	1372

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Macquarie Group's GDRX Position: Q1 2022 in Review

Macquarie Group sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 2,776 shares — an estimated $91K sold.

Macquarie Group first reported a position in GDRX in Q3 2020 and held it in 5 quarters. The position peaked at $580K in Q3 2020. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

Macquarie Group reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
Macquarie Group sold 2,776 GoodRx Holdings shares in Q1 2022, an estimated $91K.
Macquarie Group first reported a position in GoodRx Holdings in Q3 2020 and held it in 5 quarters.
Macquarie Group's GoodRx Holdings position peaked at $580K in Q3 2020.
167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Macquarie Group's 13F filing for Q1 2022, filed 16 May 2022.